自我报告可治愈和不可治愈癌症的患者之间的旅行负担差异:来自荷兰flash mob研究的结果
M A J Versluis1,2, E C S de Boer3, L V van de Poll-Franse4,5,6
1Graduate School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands. m.a.j.versluis@tilburguniversity.edu.
概括
癌症患者 癌症患者
科学领域:
- 在瘤学瘤学.
- 获得医疗保健 获得医疗保健 获得医疗保健
- 患者体验 患者体验
背景情况:
- 了解患者的旅行负担对于公平的癌症护理至关重要.
- 自我报告的疾病状态 (可治愈或不可治愈的癌症) 可能会影响医疗保健的获取和患者报告的结果.
- 旅行的挑战可以显著影响癌症患者的治疗坚持和生活质量.
研究的目的:
- 调查自我报告可治愈和无法治愈的癌症患者所经历的旅行负担.
- 确定与出行问题和愿意出行癌症治疗相关的因素.
主要方法:
- 这是一项为期两天的闪光集会研究,涉及到2023年3月65家荷兰医院.
- 991名可治愈癌症患者和1959名不可治愈癌症患者填写了有关旅行时间,问题和旅行意愿的问卷.
- 进行了描述性和后勤回归分析,以评估旅行负担和相关因素.
主要成果:
- 在疾病状态 (可治愈或不可治愈的癌症) 和遇到旅行问题或旅行意愿之间没有发现显著的关联.
- 患有可治愈癌症的患者报告说,与患有不可治愈癌症的患者相比,他们更频繁地去医院,但旅行时间更短 (<30分钟).
- 旅行问题与较差的身体功能和较长的旅行时间有关,而旅行意愿与教育水平,身体功能和瘤类型相关.
结论:
- 癌症诊断 (可治愈或不可治愈) 并没有直接影响旅行问题或旅行意愿.
- 身体功能和旅行时间是旅行问题的关键决定因素.
- 患者的教育,身体状况和瘤类型显著影响了为癌症治疗而旅行的意愿,突出了对个性化护理策略的需求.
相关概念视频
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:18Cancer
49.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:30Cancer Vaccines
520
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K